Fetal and Neonatal Heart Monitor Market Opportunities and Forecast Assessment, 2018 to 2028
Global sales of fetal and NeonatalMonitoring are likely to surpass 261,000 units in 2018, with rising adoption in the US driving sales. Cardiotocographs remain the highest selling fetal and neonatal heart monitor devices, with global sales equating a valuation of nearly US$ 400 Mn in 2017. Demand continues to remain concentrated in hospitals and neonatal clinics, with the former accounting for a leading share.
View full press release